“As the pace of technology-enabled disruption in virtually every industry continues to accelerate, Goodwin’s focus on the convergence of capital and innovation has put our technology practice at the nexus of deal activity,” said Ken Gordon, co-chair of the firm’s Technology practice. “Jean joins our team at a time of unprecedented momentum, and her strong experience in both public and private M&A will be a significant asset to our clients.”
Lee represents public and private companies and private equity funds in a variety of matters, including mergers and acquisitions, take-private transactions, divestitures, and corporate governance.
“Goodwin has a long-established presence in the technology and private equity ecosystems and is a destination firm for M&A globally,” said Lee. “I’m thrilled to partner with such an outstanding and collaborative team to continue supporting the innovators and investors who are driving the global economy.”
Over the past year, Goodwin has ranked at the top of the global M&A league tables. Refinitiv named Goodwin the number one legal advisor (by deal count) for global and U.S. M&A in Q1 2021. Mergermarket’s Deal Drivers FY 20 reports named Goodwin the number one firm (by deal count) for Pharma, Medical, and Biotech M&A in North America; the number two firm (by value) for Pharma, Medical, and Biotech M&A in Europe, the Middle East, and Africa; and the number three firm (by deal count) for Tech, Media, and Telecoms M&A in North America.
Areas of focus of Goodwin’s global Technology M&A practice include private and public company sell-sides, de-SPAC transactions, buyside work, strategic divestitures, growth equity deals, strategic joint ventures, spin-outs and carve-outs, and distressed M&A.